Systematic review and meta-analysis of the low-dose versus high-dose cyclophosphamide regimen for induction treatment in lupus nephritis patients, evidence update 2010¿2023 Pedro Arbey Quevedo Mayorga; Javier Mauricio Mora Méndez; Alejandro Aristizábal; Lilian Marcela Estupiñan Moya; Diana Muñoz;

Outcomes with the use of rituximab in patients with refractory lupus nephritis in a Colombian cohort Julián Barbosa-Arana; Juan David López-López; Sebastián Guerra-Zarama; Santiago Monsalve-Yepes; María Fernanda Saavedra-Chacón; José David Serna-Giraldo; Juan Camilo Díaz-Coronado; Diego Fernando Rojas-Gualdron; Deicy Hernandez-parra; Sebastián Herrera;

Effect of induction therapy with mycophenolate or cyclophosphamide on serum BAFF levels in patients with systemic lupus erythematosus Alejandra Betancur Herrera; Juan José Mariño Restrepo; Tulio Lopera Restrepo; Laura Robledo Montoya; Juan Felipe Soto Restrepo; Adriana Lucía Vanegas García; Carlos Horacio Muñoz Vahos; Juan Camilo Díaz Coronado; Ricardo Antonio Pineda Tamayo; Gloria Vásquez;